Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRBP · as of Jun 8, 2026
Key Statistics
Explore Corbus Pharmaceuticals Holdings, Inc. Data
crbp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 87.5%
The CRBP analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $38.50, representing +409.26% upside from the current price of $7.56.
Competitors & Peers
crbp competitorsCRBP
ALEC
APLT
CRDF
ELTX
FBRXStock Performance
Full HistoryAbout Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating immune modulators designed to combat immuno-oncology and various fibrotic conditions. Its pipeline…
what is corbus pharmaceuticals holdings, inc. · crbp stock overview · corbus pharmaceuticals holdings, inc. company profile · who is corbus pharmaceuticals holdings, inc. ceo · crbp NASDAQ · corbus pharmaceuticals holdings, inc. headquarters · corbus pharmaceuticals holdings, inc. business segments
About Stock Overview & Key Data
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 27, 2014. As of the latest trading session, CRBP stock price is $7.56, with a market capitalization of $94.8M. The stock has returned -17.92% over the past 12 months and -7.13% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Corbus Pharmaceuticals Holdings, Inc. stock is Buy, with an average 12-month price target of $38.50. In fiscal year 2025, Corbus Pharmaceuticals Holdings, Inc. reported revenue of — and net income of -$78.5M. For detailed data — including Corbus Pharmaceuticals Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock price is $7.56. The stock is traded on NASDAQ under the ticker symbol CRBP. The 52-week range is $6.72 – $20.56.